HIV-1 latency /

Saved in:
Bibliographic Details
Imprint:Cham, Switzerland : Springer, [2018]
Description:1 online resource
Language:English
Series:Current topics in microbiology and immunology, 0070-217X ; volume 417
Current topics in microbiology and immunology ; 417.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11718264
Hidden Bibliographic Details
Other authors / contributors:Silvestri, Guido (Professor of pathology and laboratory medicine), editor.
Lichterfeld, Mathias, editor.
ISBN:9783030028169
303002816X
9783030028176
3030028178
9783030028152
3030028151
Digital file characteristics:text file PDF
Notes:Online resource; title from PDF title page (SpringerLink, viewed October 18, 2018).
Summary:This volume summarizes recent advances in understanding the mechanisms of HIV-1 latency, in characterizing residual viral reservoirs, and in developing targeted interventions to reduce HIV-1 persistence during antiretroviral therapy. Specific chapters address the molecular mechanisms that govern and regulate HIV-1 transcription and latency; assays and technical approaches to quantify viral reservoirs in humans and animal models; the complex interchange between viral reservoirs and the host immune system; computational strategies to model viral reservoir dynamics; and the development of therapeutic approaches that target viral reservoir cells. With contributions from an interdisciplinary group of investigators that cover a broad spectrum of subjects, from molecular virology to proof-of-principle clinical trials, this book is a valuable resource for basic scientists, translational investigators, infectious-disease physicians, individuals living with HIV/AIDS and the general public.
Other form:Print version: HIV-1 latency. Cham, Switzerland : Springer, [2018] 3030028151 9783030028152
Standard no.:10.1007/978-3-030-02816-9

MARC

LEADER 00000cam a2200000Ii 4500
001 11718264
005 20210625184445.8
006 m o d
007 cr cnu|||unuuu
008 181015s2018 sz o 000 0 eng d
015 |a GBB8J4631  |2 bnb 
016 7 |a 019091019  |2 Uk 
019 |a 1057234690  |a 1081227959  |a 1088986537 
020 |a 9783030028169  |q (electronic bk.) 
020 |a 303002816X  |q (electronic bk.) 
020 |a 9783030028176  |q (print) 
020 |a 3030028178 
020 |z 9783030028152  |q (print) 
020 |z 3030028151 
024 7 |a 10.1007/978-3-030-02816-9  |2 doi 
035 |a (OCoLC)1056952108  |z (OCoLC)1057234690  |z (OCoLC)1081227959  |z (OCoLC)1088986537 
035 9 |a (OCLCCM-CC)1056952108 
037 |a com.springer.onix.9783030028169  |b Springer Nature 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d GW5XE  |d N$T  |d YDX  |d EBLCP  |d UKMGB  |d OCLCF  |d UAB  |d UPM  |d DKU  |d VT2  |d CAUOI  |d LEAUB  |d UKAHL  |d OCLCQ 
049 |a MAIN 
050 4 |a QR201.A37 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
072 7 |a MJCM  |2 bicssc 
072 7 |a MJCM  |2 thema 
245 0 0 |a HIV-1 latency /  |c Guido Silvestri, Mathias Lichterfeld, editors. 
264 1 |a Cham, Switzerland :  |b Springer,  |c [2018] 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current topics in microbiology and immunology,  |x 0070-217X ;  |v volume 417 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed October 18, 2018). 
505 0 |a Intro; Preface; Contents; 74 Molecular Control of HIV and SIV Latency; Abstract; 1 Introduction; 2 The HIV-1 and SIVmac Promoters; 3 Regulation of HIV-1/SIV Transcription; 3.1 Nuclear Topography; 3.2 Viral Integration Site; 3.3 Epigenetic Modifications of HIV-1/SIV Promoter; 3.4 Regulation of HIV-1 Transcription by Tat/P-TEFb; 3.5 The Role of Cellular Transcription Factors; 4 Post-transcriptional Regulation of HIV-1 Expression; 4.1 HIV-1 mRNA Processing and Latency; 4.2 Noncoding mRNAs and HIV-1 Latency; 5 Concluding Remarks; References 
505 8 |a 75 Assays to Measure Latency, Reservoirs, and ReactivationAbstract; 1 Introduction; 2 Definitions; 3 The Viral Outgrowth Assay; 3.1 Assay Design and Rationale; 3.2 Recent Improvements and Potential Problems with the QVOA; 4 The Proviral Landscape: Defective and Non-induced Proviruses; 5 Other Reservoir Assays; 5.1 PCR and Hybridization-Based Assays; 5.2 Induction Assays; 6 Other Approaches to Reservoir Measurement; 6.1 Residual Viremia; 6.2 Biomarkers; 6.3 Time to Rebound; 7 Conclusions; Acknowledgements; References; 72 The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir 
505 8 |a Abstract1 Introduction; 2 Innate Immune Response; 2.1 Type I Interferon and Restriction Factors; 2.2 Natural Killer Cells; 3 Adaptive Immune Response: Humoral Immunity; 3.1 HIV-1-Specific Antibodies; 3.2 The Development of Broadly Neutralizing Abs; 3.3 Abs as a Preventative or Therapeutic Treatment; 3.4 Bispecific Abs; 4 Adaptive Immune Response: Cellular Immunity; 4.1 HIV-1-Specific CD8+T Cells; 4.2 CD8+T Cell Responses in Patients with Natural Control of HIV-1 Infection; 4.3 CD8+T Cell Based Vaccines; 4.4 CD8+T Cell Based "Shock and Kill" Therapy; 5 Conclusions; References 
505 8 |a 73 Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral TherapyAbstract; 1 Introduction; 2 NHP/AIDS Models; 2.1 HIV-1 Infection of Nonhuman Primates; 2.2 Discovery of Simian Immunodeficiency Virus (SIV) and Simian AIDS; 2.3 SIV Infection in Different NHP Species; 3 Advantages of NHP Models for HIV/AIDS Cure Research; 4 Challenges for Using NHP/AIDS Models for HIV Cure Research; 4.1 Logistical Challenges; 4.2 Challenges in cART Administration to AIDS Virus Infected NHP; 5 Administration of Antiretroviral Drugs to NHPs 
505 8 |a 5.1 Antiretroviral Drugs That Have Been Utilized in NHPs5.2 Future cART Regimen Development for NHPs; 6 Alternative Models; 6.1 Chinese-Origin Rhesus Macaques; 6.2 RT-SHIV Infections; 6.3 SIVagm.sab Infections; 6.4 CNS Infection Models; 6.5 Envelope SHIVs; 7 Virologic Assays; 7.1 PCR and RT-PCR-Based Assays; 7.2 In Situ Approaches; 7.3 Other Virologic Assessments; 8 Concluding Remarks; Financial Support; References; 89 SIV Latency in Macrophages in the CNS; Abstract; 1 Introduction; 2 HIV Infection and SIV Infection in the CNS; 3 New Insights on Macrophage Origin and Phenotypes 
520 |a This volume summarizes recent advances in understanding the mechanisms of HIV-1 latency, in characterizing residual viral reservoirs, and in developing targeted interventions to reduce HIV-1 persistence during antiretroviral therapy. Specific chapters address the molecular mechanisms that govern and regulate HIV-1 transcription and latency; assays and technical approaches to quantify viral reservoirs in humans and animal models; the complex interchange between viral reservoirs and the host immune system; computational strategies to model viral reservoir dynamics; and the development of therapeutic approaches that target viral reservoir cells. With contributions from an interdisciplinary group of investigators that cover a broad spectrum of subjects, from molecular virology to proof-of-principle clinical trials, this book is a valuable resource for basic scientists, translational investigators, infectious-disease physicians, individuals living with HIV/AIDS and the general public. 
650 0 |a HIV infections.  |0 http://id.loc.gov/authorities/subjects/sh91004036 
650 0 |a HIV (Viruses)  |0 http://id.loc.gov/authorities/subjects/sh86004391 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Medical microbiology & virology.  |2 bicssc 
650 7 |a Pathology.  |2 bicssc 
650 7 |a Epidemiology & medical statistics.  |2 bicssc 
650 7 |a Immunology.  |2 bicssc 
650 7 |a HIV infections.  |2 fast  |0 (OCoLC)fst00949871 
650 7 |a HIV (Viruses)  |2 fast  |0 (OCoLC)fst00949837 
655 4 |a Electronic books. 
700 1 |a Silvestri, Guido  |c (Professor of pathology and laboratory medicine),  |e editor.  |0 http://id.loc.gov/authorities/names/n2012182602 
700 1 |a Lichterfeld, Mathias,  |e editor. 
776 0 8 |i Print version:  |t HIV-1 latency.  |d Cham, Switzerland : Springer, [2018]  |z 3030028151  |z 9783030028152  |w (OCoLC)1054365701 
830 0 |a Current topics in microbiology and immunology ;  |v 417.  |0 http://id.loc.gov/authorities/names/n42036058 
903 |a HeVa 
929 |a oclccm 
999 f f |i 0038a68c-d165-52ef-bbf9-192bfc6b242b  |s a8d2dcc7-3ed7-5ae5-81c9-8f4655a2622c 
928 |t Library of Congress classification  |a QR201.A37  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-3-030-02816-9  |z Springer Nature  |g ebooks  |i 12557853